ID
39315
Beschrijving
1st Line Treatment of Bevacizumab-Taxane vs Bevacizumab-Exemestane in Metastatic Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT01303679
Link
https://clinicaltrials.gov/show/NCT01303679
Trefwoorden
Versies (1)
- 18-12-19 18-12-19 -
Houder van rechten
See clinicaltrials.gov
Geüploaded op
18 december 2019
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Eligibility First Line Metastatic Breast Cancer NCT01303679
Eligibility First Line Metastatic Breast Cancer NCT01303679
- StudyEvent: Eligibility
Beschrijving
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Beschrijving
Prior Adjuvant Therapy | exemestane | Prior Therapy metastatic
Datatype
boolean
Alias
- UMLS CUI [1]
- C1514456
- UMLS CUI [2]
- C0851344
- UMLS CUI [3,1]
- C1514463
- UMLS CUI [3,2]
- C1522484
Beschrijving
Cemotherapeutics regimen first line of treatment | Except Paclitaxel | Except Bevacizumab
Datatype
boolean
Alias
- UMLS CUI [1]
- C2045825
- UMLS CUI [2,1]
- C0332300
- UMLS CUI [2,2]
- C0144576
- UMLS CUI [3,1]
- C0332300
- UMLS CUI [3,2]
- C0796392
Beschrijving
Prior Therapy | Paclitaxel | bevacizumab
Datatype
boolean
Alias
- UMLS CUI [1]
- C1514463
- UMLS CUI [2]
- C0144576
- UMLS CUI [3]
- C0796392
Beschrijving
HER2 Positive | Estrogen receptor negative
Datatype
boolean
Alias
- UMLS CUI [1]
- C2348909
- UMLS CUI [2]
- C0279756
Beschrijving
Thrombosis Event Previous
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C0040053
- UMLS CUI [1,2]
- C0441471
- UMLS CUI [1,3]
- C0205156
Beschrijving
Prior surgery
Datatype
boolean
Alias
- UMLS CUI [1]
- C0455610
Beschrijving
Blood Coagulation Disorder Previous
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C0005779
- UMLS CUI [1,2]
- C0205156
Similar models
Eligibility First Line Metastatic Breast Cancer NCT01303679
- StudyEvent: Eligibility
C3495949 (UMLS CUI [2])
C2348908 (UMLS CUI [2])
C0144576 (UMLS CUI [2])
C0796392 (UMLS CUI [3])
C0851344 (UMLS CUI [2])
C1514463 (UMLS CUI [3,1])
C1522484 (UMLS CUI [3,2])
C0332300 (UMLS CUI [2,1])
C0144576 (UMLS CUI [2,2])
C0332300 (UMLS CUI [3,1])
C0796392 (UMLS CUI [3,2])
C0144576 (UMLS CUI [2])
C0796392 (UMLS CUI [3])
C0279756 (UMLS CUI [2])
C0441471 (UMLS CUI [1,2])
C0205156 (UMLS CUI [1,3])
C0205156 (UMLS CUI [1,2])